Symptom profiles in lung cancer survivors: A latent class approach

肺癌幸存者的症状特征:一种潜在类别方法

阅读:1

Abstract

Lung cancer survivors experience multiple concurrent symptoms after cancer treatments. However, the majority of symptom research has focused on assessing and managing individual symptoms. Furthermore, little is known about the risk factors and adverse outcomes of complex symptoms in lung cancer survivors. The purpose of the study was to: (1) identify symptom profiles in lung cancer survivors; (2) determine influencing factors of the symptom profiles; and (3) examine differences in health outcomes among the symptom profiles. A cross-sectional secondary analysis of data from the Measuring Your Health (MY-Health) study was conducted with 526 lung cancer survivors. Symptom profiles were identified using latent profile analysis based on four patient-reported symptoms (pain, fatigue, sleep disturbance, and depression) with custom PROMIS® short forms. We conducted multinomial logistic regression analysis to determine influencing factors of the symptom profiles and multivariate analysis of variance to examine differences in physical function and social function among the symptom profiles. Four latent class symptom profiles were identified: (1) Within Normal Limits (Class 1), (2) Pain with Fatigue and Sleep Disturbance (Class 2), (3) Depression with Fatigue and Sleep disturbance (Class 3), and (4) All High Symptom Burden (Class 4). Age, income, employment status, and number of comorbidities were the influencing factors of the symptom profiles. There were significant differences in physical function and social function among the symptom profiles. This study found that the influencing factors of the symptom profiles in lung cancer survivors tended to be more sociodemographic in nature, rather than clinical. Researchers and healthcare providers use findings such as these when establishing symptom management strategies for lung cancer survivors by integrating demographic and socioeconomic determinants of health in conjunction with targeted clinical variables.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。